Evidence map›Paper›PMID 35447698›Full record

ArticleBioengineering (Basel, Switzerland)2022

Clinical Evaluation on the Performance and Safety of a Non-Ablative Fractional 1340 nm Laser for the Treatment of Stretch Marks in Adolescents and Young Adults: A Case Series.

Maria Teresa Viviano, Alessia Provini, Cinzia Mazzanti, Steven Paul Nisticò, Cataldo Patruno, Giovanni Cannarozzo, Stefano Bennardo, Irene Fusco, Luigi Bennardo

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Advances in the Treatment of Striae Distensae.Journal of cosmetic dermatology · 2026
    Pooled it
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Fractional COHealthcare (Basel, Switzerland) · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria Teresa VivianoOspedale San Pietro-Fatebenefratelli, 00100 Rome, Italy.
Alessia ProviniIstituto Dermopatico dell'Immacolata, 00100 Rome, Italy.
Cinzia MazzantiOspedale San Pietro-Fatebenefratelli, 00100 Rome, Italy.
Steven Paul NisticòDepartment of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Cataldo PatrunoDepartment of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy.ORCID 0000-0001-8661-2822
Giovanni CannarozzoDepartment of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Stefano BennardoDepartment of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
Irene FuscoDepartment of Pharmacology, Università degli Studi di Firenze, 50100 Florence, Italy.ORCID 0000-0001-7264-8808
Luigi BennardoDepartment of Health Sciences, Magna Graecia University, 88100 Catanzaro, Italy.ORCID 0000-0002-0434-1027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large part of the world’s population suffers from Striae distensae (SD) or stretch marks, which create physical and psychological discomfort in people. We evaluate the SD clinical improvement by using a non-ablative fractional Nd:YAP 1340 nm laser. The research was performed on 25 patients of both sexes, with a mean age of 31 ± 13.09 years. Each patient underwent from a minimum of 3 to a maximum of 4 treatments, with an Nd:YAP (1340 nm) medical device, every four weeks, with 3- and 6-month follow-up, in these areas: back, abdomen, breast, flanks, lower limbs, buttocks, and thighs. Manchester Scar Scale assessed stretch marks improvement. Side effects, patient pain, and SD overall appearance improvement were also recorded for all patients. Digital photographs measured the aesthetic results. Treatment was well-tolerated (pain score 1.08 ± 0.76) by all patients. There were no long-term side effects, and 88% of patients revealed an SD excellent improvement showing good aesthetic results achieved by the treatment. The total mean pretreatment Manchester Scar Scale score decreased from 13.80 (±1.58) to 10.36 (±1.70) after 3 months (p < 0.01) and to 8.36 (±1.07) after 6 months (p < 0.01). An Nd:YAP (1340 nm) laser seems to be a safe and effective treatment, showing a higher security profile with no side effects.

Indexed as

non-ablative fractional laserstretch marksstriae

Identifiers

PMID35447698
PMCPMC9027695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.